Reliance Chemotex Intrinsic Value
Reliance Chemotex intrinsic value. Reliance Chemotex (RELCHEMQ) median intrinsic value is ₹172.52 from 9 valuation models (range ₹34–₹255), vs current price ₹113.40 — +52.1% upside (Trading Below Calculated Value), margin of safety 34.3%. Read RELCHEMQ ex-dividend dates for the complete payout history and dividend yield track record.
RELCHEMQ Valuation Methods Summary — DCF, Graham Number & P/E
Reliance Chemotex intrinsic value across 9 models vs current price ₹113.40 — upside/downside and value range per method. Compare with Reliance Chemotex valuation methods to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹88.80 | ₹71.04 - ₹106.56 | -21.7% | EPS: ₹7.40, Sector P/E: 12x |
| Book Value Method | asset | ₹178.75 | ₹160.88 - ₹196.63 | +57.6% | Book Value/Share: ₹178.75, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹226.80 | ₹204.12 - ₹249.48 | +100.0% | Revenue/Share: ₹466.25, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹226.80 | ₹204.12 - ₹249.48 | +100.0% | EBITDA: ₹45.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹255.30 | ₹204.24 - ₹306.36 | +125.1% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹47.36 | ₹42.62 - ₹52.10 | -58.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹59.24 | ₹53.32 - ₹65.16 | -47.8% | Revenue Growth: 0.1%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹172.52 | ₹155.27 - ₹189.77 | +52.1% | EPS: ₹7.40, BVPS: ₹178.75 |
| Dividend Yield Method | dividend | ₹34.02 | ₹30.62 - ₹37.42 | -70.0% | DPS: ₹0.50, Target Yield: 3.5% |
RELCHEMQ Intrinsic Value vs Market Price — All Valuation Models
Reliance Chemotex fair value range ₹34–₹255 vs current market price ₹113.40 across 9 valuation models. For current market price and key ratios, visit Reliance Chemotex screener.
RELCHEMQ Intrinsic Value Analysis — Undervalued or Overvalued?
Reliance Chemotex median intrinsic value ₹172.52, current price ₹113.40 — Trading Below Calculated Value by 52.1%, margin of safety 34.3%.
What is the intrinsic value of RELCHEMQ?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Reliance Chemotex (RELCHEMQ) is ₹172.52 (median value). With the current market price of ₹113.40, this represents a +52.1% variance from our estimated fair value.
The valuation range spans from ₹34.02 to ₹255.30, indicating ₹34.02 - ₹255.30.
Is RELCHEMQ undervalued or overvalued?
Based on our multi-method analysis, Reliance Chemotex (RELCHEMQ) appears to be trading below calculated value by approximately 52.1%.
RELCHEMQ Financial Health — Key Ratios vs Industry Benchmarks
Reliance Chemotex financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.92 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 4.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.73x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RELCHEMQ Cash Flow Quality — Operating & Free Cash Flow
Reliance Chemotex operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹22 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹11 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹18 Cr | ₹-23 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹0 Cr | ₹-26 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹59 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |